Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 397 participants.

Also called NCT03683030

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 397 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03683030
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, China, Italy (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03683030. Allocation not applicable; no masking; primary purpose treatment. Start 2018-10-22 (actual); primary completion 2022-02-18 (actual). Results posted on 2025-08-15.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation
Acronym
STELLAR
Intervention (Device)
Multi-Electrode RF Balloon Catheter
Lead sponsor
Biosense Webster, Inc. (class: industry)

Record details

Record id
cardio:ct-nct03683030
Content hash
93e4fe03056ff0f01fcbca5942bdb52687313efd73d26403e92bad494f41aad0